Published in Biochim Biophys Acta on July 12, 1996
Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev (2011) 2.48
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem Biol (2007) 2.05
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther (2009) 1.74
Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol (2003) 1.50
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol (2009) 1.46
Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium-dependent pathway in lyso-PtdCho-induced demyelination. J Neurosci Res (2007) 1.39
Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J Neurosci (2011) 1.32
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol (2007) 1.25
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase. J Pharmacol Exp Ther (2008) 1.17
Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides. J Med Chem (2006) 1.06
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum. J Physiol (2011) 1.04
Role of Ca2+-independent phospholipase A2 in cell growth and signaling. Biochem Pharmacol (2008) 1.02
Role of cytosolic phospholipase A(2) in retinal neovascularization. Invest Ophthalmol Vis Sci (2009) 1.00
Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J Med Chem (2010) 0.97
Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamics. J Am Chem Soc (2013) 0.95
Functional characterization of a phospholipase A(2) homolog from Rickettsia typhi. J Bacteriol (2010) 0.95
Reorganization of actin cytoskeleton by the phosphoinositide metabolite glycerophosphoinositol 4-phosphate. Mol Biol Cell (2003) 0.94
Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction. J Cardiovasc Pharmacol (2009) 0.92
Pasteurella haemolytica A1-derived leukotoxin and endotoxin induce intracellular calcium elevation in bovine alveolar macrophages by different signaling pathways. Infect Immun (1998) 0.90
Rickettsia typhi possesses phospholipase A2 enzymes that are involved in infection of host cells. PLoS Pathog (2013) 0.89
Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils. Br J Pharmacol (2006) 0.88
New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2. Bioorg Med Chem (2013) 0.86
Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory. Psychopharmacology (Berl) (2005) 0.85
Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry. PLoS One (2013) 0.85
Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death. J Neurochem (2008) 0.84
Arachidonate release and prostaglandin production by group IVC phospholipase A2 (cytosolic phospholipase A2gamma). Biochem J (2003) 0.83
Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid. Proc Natl Acad Sci U S A (2011) 0.82
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries. Eur J Pharmacol (2009) 0.82
Phospholipase A2, oxidative stress, and neurodegeneration in binge ethanol-treated organotypic slice cultures of developing rat brain. Alcohol Clin Exp Res (2013) 0.82
Temporally resolved cAMP monitoring in endothelial cells uncovers a thrombin-induced [cAMP] elevation mediated via the Ca²+-dependent production of prostacyclin. J Physiol (2010) 0.82
Cytosolic phospholipase A2alpha activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.82
Involvement of different protein kinases and phospholipases A2 in phorbol ester (TPA)-induced arachidonic acid liberation in bovine platelets. Mediators Inflamm (2000) 0.81
Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK. Br J Pharmacol (1999) 0.81
Effect of Extremely Low Frequency Electromagnetic Fields (EMF) on Phospholipase Activity in the Cultured Cells. Korean J Physiol Pharmacol (2010) 0.80
The ω3-polyunsaturated fatty acid derivatives AVX001 and AVX002 directly inhibit cytosolic phospholipase A(2) and suppress PGE(2) formation in mesangial cells. Br J Pharmacol (2012) 0.80
Morinda citrifolia Inhibits Both Cytosolic Ca-dependent Phospholipase A(2) and Secretory Ca-dependent Phospholipase A(2). Korean J Physiol Pharmacol (2010) 0.79
Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.79
Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds. Dis Model Mech (2011) 0.79
IL-6 release from mouse glia caused by MeHg requires cytosolic phospholipase A2 activation. Neurosci Lett (2009) 0.79
Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. J Neural Transm (Vienna) (2011) 0.77
Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ. Urology (2010) 0.76
Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA). Cell Signal (2008) 0.76
Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4. Clin Exp Immunol (2001) 0.76
Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus. J Neural Transm (Vienna) (2014) 0.76
Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease. J Biol Chem (2016) 0.75
Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell disease. Sci Rep (2016) 0.75
Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A2. Bioorg Med Chem (2016) 0.75
PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy. Sci Rep (2017) 0.75
Activation of group IVC phospholipase A(2) by polycyclic aromatic hydrocarbons induces apoptosis of human coronary artery endothelial cells. Arch Toxicol (2010) 0.75
Phospholipase A2 mediates apolipoprotein-independent uptake of chylomicron remnant-like particles by human macrophages. Int J Vasc Med (2011) 0.75
The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta (2000) 4.62
Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A (1999) 2.85
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81
Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem (1987) 2.75
Lipid signaling enzymes and surface dilution kinetics. J Biol Chem (1995) 2.41
Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem (1995) 2.23
Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim Biophys Acta (1983) 2.05
Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol (1999) 1.98
Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci (2001) 1.82
The geometry of the transition state in the hydrolysis of phosphate esters. J Am Chem Soc (1966) 1.81
Intracellular sites of lipid synthesis and the biogenesis of mitochondria. J Lipid Res (1972) 1.66
Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc Natl Acad Sci U S A (1995) 1.61
Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci U S A (1999) 1.58
Kinetic analysis of phospholipase A2 activity toward mixed micelles and its implications for the study of lipolytic enzymes. J Biol Chem (1975) 1.55
The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem (2000) 1.54
Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J Biol Chem (1996) 1.54
Calcium-independent phospholipase A(2): structure and function. Biochim Biophys Acta (2000) 1.53
Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity. Biochemistry (1982) 1.53
Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization. J Biol Chem (1994) 1.52
The mechanism of action of ribonuclease. Proc Natl Acad Sci U S A (1969) 1.51
Chemical modification of the histidine residue in phospholipase A2 (Naja naja naja). A case of half-site reactivity. J Biol Chem (1977) 1.44
Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J Mol Evol (1990) 1.40
Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J Biol Chem (1997) 1.37
Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry (1989) 1.36
Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J Biol Chem (1996) 1.35
Function and inhibition of intracellular calcium-independent phospholipase A2. J Biol Chem (1997) 1.34
Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J Biol Chem (1997) 1.31
Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem (1990) 1.30
Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity. J Biol Chem (1998) 1.25
Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader. Anal Biochem (1992) 1.20
Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide. Am J Pathol (1978) 1.19
Kinetic dependence of phospholipase A 2 activity on the detergent Triton X-100. J Lipid Res (1973) 1.19
Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine. J Biol Chem (1996) 1.16
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16
Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem (1999) 1.15
Enzymatic synthesis and decarboxylation of phosphatidylserine in Tetrahymena pyriformis. J Lipid Res (1970) 1.15
Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. Biochim Biophys Acta (1993) 1.14
Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J Biol Chem (1996) 1.13
Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J Neurochem (1999) 1.12
Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells. J Biol Chem (1993) 1.06
Phospholipase A2 activity towards phosphatidylcholine in mixed micelles: surface dilution kinetics and the effect of thermotropic phase transitions. Arch Biochem Biophys (1973) 1.06
Photoactivated heterobifunctional cross-linking reagents which demonstrate the aggregation state of phospholipase A2. Biochemistry (1977) 1.05
Phospholipase A2 from cobra venom (Naja naja naja). Methods Enzymol (1981) 1.04
Mammalian lysophospholipases. Biochim Biophys Acta (1999) 1.04
Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2. Proc Natl Acad Sci U S A (1998) 1.03
Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes. Proc Natl Acad Sci U S A (1994) 1.03
Attitudes of women toward the gynecologic examination. J Fam Pract (1979) 1.02
Cellular regulation of cytosolic group IV phospholipase A2 by phosphatidylinositol bisphosphate levels. J Immunol (2000) 1.00
Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. Biochim Biophys Acta (1999) 1.00
Phospholipid activation of cobra venom phospholipase A2. 1. Lipid--lipid or lipid--enzyme interaction. Biochemistry (1979) 0.99
Analysis of phospholipase C (Bacillus cereus) action toward mixed micelles of phospholipid and surfactant. Arch Biochem Biophys (1976) 0.99
Dual role of interfacial phospholipid in phospholipase A2 catalysis. Proc Natl Acad Sci U S A (1977) 0.98
Phospholipid activation of cobra venom phospholipase A2. 2. Characterization of the phospholipid--enzyme interaction. Biochemistry (1979) 0.98
Assay strategies and methods for phospholipases. Methods Enzymol (1991) 0.98
Regulation of delayed prostaglandin production in activated P388D1 macrophages by group IV cytosolic and group V secretory phospholipase A2s. J Biol Chem (1999) 0.97
Activation, aggregation, and product inhibition of cobra venom phospholipase A2 and comparison with other phospholipases. J Biol Chem (1985) 0.97
1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal Biochem (1994) 0.97
Interfacial activation, lysophospholipase and transacylase activity of group VI Ca2+-independent phospholipase A2. Biochim Biophys Acta (1998) 0.96
Solubilization, purification, and characterization of a membrane-bound phospholipase A2 from the P388D1 macrophage-like cell line. J Biol Chem (1988) 0.96
Crystal structure of phospholipase A2 from Indian cobra reveals a trimeric association. Proc Natl Acad Sci U S A (1993) 0.96
Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine triphosphate. J Biol Chem (1999) 0.95
Kinetic analysis of the Ca2+-dependent, membrane-bound, macrophage phospholipase A2 and the effects of arachidonic acid. J Biol Chem (1988) 0.95
Structures of two novel crystal forms of Naja naja naja phospholipase A2 lacking Ca2+ reveal trimeric packing. J Mol Biol (1998) 0.94
Identification of a third pathway for arachidonic acid mobilization and prostaglandin production in activated P388D1 macrophage-like cells. J Biol Chem (2000) 0.93
Kinetic analysis of the dual phospholipid model for phospholipase A2 action. J Biol Chem (1984) 0.93
Affinity chromatography of phospholipase A2 from Naja naja naja (Indian cobra) venom. Toxicon (1985) 0.93
Mammalian calcium-independent phospholipase A2. Biochim Biophys Acta (1995) 0.93
The specificity of phospholipase A2 and phospholipase C in a mixed micellar system. J Biol Chem (1978) 0.92
Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase inhibitor. J Biol Chem (1985) 0.92
Regulation of cyclooxygenase-2 expression by phosphatidate phosphohydrolase in human amnionic WISH cells. J Biol Chem (1999) 0.91
Involvement of phosphatidate phosphohydrolase in arachidonic acid mobilization in human amnionic WISH cells. J Biol Chem (1998) 0.91
Immobilized phospholipase A2 from cobra venom. Prevention of substrate interfacial and activator effects. J Biol Chem (1985) 0.91
Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2. Biochem Pharmacol (1989) 0.90
Action of cobra venom phospholipase A2 on the gel and liquid crystalline states of dimyristoyl and dipalmitoyl phosphatidylcholine vesicles. J Biol Chem (1979) 0.90
Conformation of micellar phospholipid bound to the active site of phospholipase A2. Biochemistry (1995) 0.89
Characterization and physical properties of the major form of phospholipase A2 from cobra venom (Naja naja naja) that has a molecular weight of 11,000. J Biol Chem (1975) 0.89
The interaction of phospholipase A2 with phospholipid analogues and inhibitors. J Biol Chem (1990) 0.89
Differential regulation of phospholipase D and phospholipase A2 by protein kinase C in P388D1 macrophages. Biochem J (1997) 0.89
VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. Br J Pharmacol (2001) 0.89
Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2. Neuroscience (2005) 0.89
Regiospecificity and catalytic triad of lysophospholipase I. J Biol Chem (1997) 0.89
Spectral perturbations of the histidine and tryptophan in cobra venom phospholipase A2 upon metal ion and mixed micelle binding. J Biol Chem (1977) 0.89
Expression and characterization of human group V phospholipase A2. Biochim Biophys Acta (1998) 0.89
Lysophospholipases I and II from P388D1 macrophage-like cell line. Methods Enzymol (1991) 0.89
Activation, aggregation, inhibition and the mechanism of phospholipase A2. Adv Exp Med Biol (1990) 0.88
Purification and characterization of a lysophospholipase from a macrophage-like cell line P388D1. J Biol Chem (1988) 0.88
A phospholipase D-mediated pathway for generating diacylglycerol in nuclei from Madin-Darby canine kidney cells. J Biol Chem (1995) 0.88
Cloning, expression, and catalytic mechanism of murine lysophospholipase I. J Biol Chem (1997) 0.88